Condition
Weight Reduction
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 8 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
8 shownGeorgia CEAL RESTORES Family Diabetes StudyNCT07808723 · 2026-08-29
RECRUITINGLow-Dose Semaglutide for Weight Loss in Obese Non-Diabetic Pakistani AdultsNCT07513168 · 2025-08-01
RECRUITINGOnline Family Dyadic Skills Training for Black Adults in Behavioral Weight Loss ProgramNCT05981508 · 2024-02-05
COMPLETEDStudy Of Weight Development Over TimeNCT02227043 · 2014-09-01
COMPLETEDImproving Patient Decisions About Bariatric SurgeryNCT02364128 · 2014-01-01
COMPLETEDEfficacy of Self-hypnosis for Weight Loss in Type 2 DiabeticsNCT02769585 · 2013-07-01
COMPLETEDAvoiding Diabetes After Pregnancy TrialNCT01923350 · 2011-12-01
COMPLETEDEffects of Protein-Enriched Meal on Liver, Kidney or Bone: a Randomized Controlled TrialNCT01030354 · 2004-07-01
COMPLETEDCommon interventions
CDE trainingBEHAVIORAL1Decider Guider: Weight LossBEHAVIORAL1Family Diabetes PreventionBEHAVIORAL1Herbalife Meal ReplacementsDIETARY_SUPPLEMENT1Locally available low-dose semaglutide (0.25 mg, 0.5 mg, 1 mg)DRUG1Not tested for diabetesBEHAVIORAL1Self-hypnosisBEHAVIORAL1Tested for diabetesBEHAVIORAL1Together, Eating and Activity, Matter Plus (TEAM+) In-PersonBEHAVIORAL1Together, Eating and Activity, Matter Plus (TEAM+) OnlineBEHAVIORAL1Weight Reduction Control ArmBEHAVIORAL1Weight Reduction InterventionBEHAVIORAL1
Leading sponsors
Trial status mix
COMPLETED6
RECRUITING2
Phase mix
NA4
PHASE22
PHASE31
PHASE41
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.